Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Novavax Inc

FDA Sets Review Dates For Pfizer, Moderna COVID-19 Shot For Kids, Plus Novavax EUA

The FDA has set up June meeting dates to review COVID-19 vaccine submissions, noting that the dates are tentative as none of the submissions are complete. The agency reserved June 8, 21, and 22 for virtual meetings of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) to review Moderna Inc (NASDAQ: MRNA) and Pfizer Inc (NYSE: PFE)…

Benzinga

Novavax's COVID-19/Influenza Combo Vaccine Shows Immunogenicity In Early-Study

Novavax Inc (NASDAQ:NVAX) has announced initial results from the Phase 1/2 trial of its COVID-Influenza Combination Vaccine (CIC), combining the COVID-19 vaccine, NVX-CoV2373, and its quadrivalent influenza vaccine candidate. The CIC trial demonstrated that the combination vaccine is feasible, well-tolerated, and immunogenic. The safety and tolerability profile of the combination vaccine was consistent…

Benzinga

What's Going On With Novavax Stock Today?

Novavax Inc (NASDAQ: NVAX) shares are trading lower Tuesday. The stock fell to new 52-week lows early in the session, but has since recovered.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Japan's Health Ministry Panel OKs Approval Of Novavax's COVID-19 Vaccine: Report

Japan's health ministry panel authorized a plan to approve Novavax Inc's (NASDAQ:NVAX) COVID-19 vaccine, which is set to be the fourth such vaccine to be approved in Japan. It will be available for first and second shots with an interval of three weeks. The Novavax product is a recombinant protein vaccine that uses…

Benzinga

Novavax's COVID-19 Vaccine Approved In Switzerland

Swissmedic, the Swiss Agency for Therapeutic Products, has granted conditional marketing authorization for Novavax Inc's (NASDAQ:NVAX) Nuvaxovid COVID-19 Vaccine for individuals 18 years of age and older. The vaccine, also known as NVX-CoV2373, is the first protein-based vaccine authorized for use in Switzerland. The Swissmedic decision was based on two pivotal Phase 3 clinical…

Benzinga

3 Stocks with Monster Upside Potential, According to Wall Street

Despite the recent market pullback due to rising Treasury yields, expectations regarding the Fed’s tighter monetary policy, and declining oil prices amid COVID-19 lockdowns imposed in China, quality growth stocks that seem relatively resistant to the market’s uncertainties are attracting investors’ attention. Thus, Wall Street analysts suggest buying fundamentally solid…

StockNews.com

What's Going On With Novavax Shares Today?

Novavax Inc (NASDAQ: NVAX) shares are trading significantly lower Tuesday. According to data from Benzinga Pro, Tuesday's trading volume is in line with Novavax's average trading volume over a 100-day period.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

EMA Starts Review Of Sanofi-GlaxoSmithKline's COVID-19 Vaccine

The European Medicines Agency has started reviewing Sanofi SA (NASDAQ:SNY) and its partner GlaxoSmithKline Plc's (NYSE:GSK) application seeking conditional authorization for their COVID-19 vaccine. The vaccine candidate, Vidprevtyn, was already being evaluated under a rolling review by EMA. The drugmakers had earlier said that they would seek regulatory approval for their COVID-19 vaccine to be…

Benzinga

Novavax's COVID-19 Vaccine Scores Green Light In India with First Approval For Adolescents

Novavax Inc's (NASDAQ:NVAX) COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years. The authorization is a global first approval in adolescents for the vaccine manufactured and marketed in India by the Serum Institute of India under the brand name Covovax. Novavax said…

Benzinga

Novavax says its COVID vaccine gets India authorisation for teens

Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.

Reuters

What's Going On With Novavax Shares Today?

Novavax Inc (NASDAQ: NVAX) is trading higher Tuesday after the company reported fourth-quarter financial results and issued guidance expecting a surge in revenue.

Benzinga

Novavax's COVID-19 Vaccine Scores Canadian Approval

Health Canada approves Novavax Inc's (NASDAQ: NVAX) Nuvaxovid COVID-19 Vaccine in individuals 18 years of age and older.

Benzinga

Novavax's COVID-19 Vaccine Shows 80% Effectiveness In Adolescent Study

Novavax Inc (NASDAQ: NVAX) said that its two-dose COVID-19 vaccine was

Benzinga

Novavax underdelivers on COVID vaccine promises

Novavax Inc has delivered just a small fraction of the 2 billion COVID-19 shots it plans to send around the world in 2022 and has delayed first-quarter shipments in Europe and lower income countries such as the Philippines, public officials involved in their government's vaccine rollouts told Reuters.

Reuters

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Germany's Vaccine Commission Recommends Novavax's COVID-19 Vaccine For Adults: Reuters

Germany's expert panel on vaccine use has recommended Novavax Inc's (NASDAQ:

Benzinga

Why Novavax Shares Are Rising Today

Novavax Inc (NASDAQ: NVAX) is trading higher Monday after the company submitted a request to the U.S Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine, NVX-CoV2373.

Benzinga

Israel Inks COVID-19 Vaccine Deal With Novavax

Israel's Ministry of Health has agreed to purchase Novavax Inc's (NASDAQ: NVAX) protein-based COVID-19 vaccine candidate, NVX-CoV2373.

1 2

People

Mangeet Kaur BounsMangeet

595 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

European Medicines Agency

76 stories

NVAX

62 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.